medical mobile apps: the regulatory story

39
Regulatory Story Mobile Medical Apps (MMAs)

Upload: tedxyouthsnellparade

Post on 21-Apr-2017

813 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Regulatory Story

Mobile Medical Apps (MMAs)

Mobile apps are everywhere

Is Pharma ready for its challenges?

On a mission to breathe digitalife into life sciences through technological – and humanistic – empowerment of patients, HCPs, and other healthcare stakeholders.

www.nadjabester.com

Nadja Bester

Group Digital Marketing Associate

at Aspen Pharmacare

@NadjaBester

Hello!

Is Pharma ready for its challenges?

Our findings indicate

that the long-

expected mobile

revolution in

healthcare is set to

happen. Both

healthcare providers

and consumers are

embracing

smartphones as a

means to improve

healthcare.

Ralf-Gordon Jahns,

Head of Research at

researche2guidance.

MMAs and Their Regulatory Story

1 Stakeholders in MMAs

2 Which MMAs are Regulated, and How?

3 Risks Posed by MMAs

4 The Way Forward

© Nadja Bester

Regulatory Enforcement Guidelines

FDA on MMA’s

© Nadja Bester

The reality is that apps can pose a serious threat to patients' health if and when it doesn't function as intended

Stakeholders in MMAs

PART ONE

© Nadja Bester

Policymakers acknowledge

benefits of MMAs

Big step

© Nadja Bester

FDA released

final guidelines

Key Action

© Nadja Bester

Payers starting

to reimburse apps

Monetary value

© Nadja Bester

Doctors suggest

apps to patients

Adoption

© Nadja Bester

Patients use apps

to improve health

Drivers

© Nadja Bester

Which MMAs are Regulated, and How?

PART TWO

© Nadja Bester

Apps most heavily regulated by FDA:

Apps operating as medical devices that can directly affect a patient's health outcomes

© Nadja Bester

Apps least heavily regulated by FDA:

Low-risk info systems that transmit published health info / provide general education tools

© Nadja Bester

Apps least heavily regulated by FDA:

Disease-self-management tools that don’t provide

specific treatment / treatment suggestions.

© Nadja Bester

Apps least heavily regulated by FDA:

Patient tools to organise and track health information.

© Nadja Bester

Apps least heavily regulated by FDA:

Document, show, or communicate

potential medical conditions to HCPs.

© Nadja Bester

Apps least heavily regulated by FDA:

Apps that provide medication reminders

© Nadja Bester

Apps least heavily regulated by FDA:

Simple task automation for HCPs.

© Nadja Bester

Apps least heavily regulated by FDA:

Patients’ or providers’ interaction with personal health

records (PHR) or electronic health records (EHR).

© Nadja Bester

Grey areas in FDA’s MMA Regulation:

Apps that link to patients‘

medication ordering systems

© Nadja Bester

Grey areas in FDA’s MMA Regulation:

Clinical decision support (CDS) apps

© Nadja Bester

CDS used in conjunction

with certain products =

drug labelling

drug advertising and promotion rules apply © Nadja Bester

" FDA intends to apply its regulatory oversight to only those mobile apps that

are medical devices and whose functionality could pose a risk to a patient’s

safety if the mobile app were to not function as intended. The FDA believes

that this subset of mobile medical apps poses the same or similar potential

risks to the public health as currently regulated devices if they fail to

function as intended.

" FDA Guidelines on Regulatory Enforcement Approach to Mobile Medical Applications

© Nadja Bester

Risks Posed by MMAs

PART THREE

© Nadja Bester

" If a mobile app is intended for use in performing a medical device function

(i.e. for diagnosis of disease or other conditions, or the cure, mitigation,

treatment, or prevision of disease) it is a medical device, regardless of the

platform on which it is run.

" FDA Guidelines on Regulatory Enforcement Approach to Mobile Medical Applications

© Nadja Bester

When Pharma does MMAs,

it needs to get done RIGHT

Case Study:

Pfizer’s Rheumatology Calculator

Recalled due to ‘buggy’ software

SAFEGUARD:

Software diagnosis =

EU Class IIA / FDA Class I

CDS apps IEC 62304 standard requirements

© Nadja Bester

Case Study:

Janssen’s PASI MMA

Issued Raised:

Legal disclaimers:

• Not to rely on data

to make diagnoses

• MMA’s status on data collection

Technical details:

• Equation scores used

in MMA calculators

© Nadja Bester

The Way

Forward

PART FOUR

© Nadja Bester

Development of MMAs is in its infancy.

Innovation is the way of the future,

but in life sciences, think before you leap.

© Nadja Bester

Is it wanted?

Don’t develop an app you think someone needs.

© Nadja Bester

Is it legal?

Be ingenious but stay within bounds.

© Nadja Bester

Is it safe?

Don’t go messing with people’s lives.

They only have one.

© Nadja Bester

Is it the best way to build your brand?

Don’t develop MMAs for the sake of doing it.

Identify a real need, then have your app fill it.

© Nadja Bester

THANK YOU! Listening is a skill, and you rocked it!